ARCHIVES

Ethics Commission Acknowledges Weak Case For Mandatory Patient Compensation

This article is from The Cancer Letter archive.

Vol. 08 No. 17 | April 23, 1982

Download PDF Visit The Full Archive

Related Articles

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

Upton Finds Work For Former Division, Program Directors

September 14, 1979

Clinical Research Program Announcement

February 13, 1981

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979